A Study to Describe the Breast Cancer Patient Population, Treatment, and Results in Indian Patients Receiving Combinations of the Medicines Called Palbociclib for Advanced Breast Cancer

NCT05584644 · clinicaltrials.gov ↗

COMPLETED

Status

150

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Cancer
Breast Carcinoma
Breast Neoplasms
Breast Tumors
Cancer of Breast

Interventions

DRUG: Palbociclib plus hormonal treatment - first line treatment
DRUG: Palbociclib plus hormonal treatment - second line treatment

Sponsor

Pfizer